Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
₹ 478
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Greatly undervalued vs peers
Data is available to registered users only
Data is available to registered users only
About
Coral Laboratories Ltd. engages in the manufacture of pharmaceutical formulations. It operates through the following geographical segments: Ethopia, India, and Rest of World. Its products include tablets, capsules, liquids, topical preparations, eye and ear drops, and injectables. The company was founded on June 19, 1981 and is headquartered in Mumbai, India.
Company Valuation
From both historical and forecast perspectives, the stock is considerably underpriced compared to similar stocks. In particular, the stock is underpriced on P/E, 'cheap'
Data is available to registered users only
Buy
Sell